What We're Reading: Maternal Mortality Rates; FDA Rejects Li

A new grant aims to address maternal mortality in predominantly Black rural areas; Eli Lilly's drug to treat atopic dermatitis has not received FDA approval; a preliminary injunction is granted to Planned Parenthood South Atlantic.

Related Keywords

New Hampshire , United States , Eli Lilly , Obstetrics Management Strategies Program , Reuters , Health Resources , Services Administration , Kaiser Health News , Institute For The Advancement Of Minority Health , Targeting High Maternal Mortality Rates , Majority Black Rural , Deep South , Kaiser Health , Rural Maternity , Mississippi Based Institute , Minority Health , Mary Hitchcock Memorial Hospital , Eczema Drug Due , Maternal Mortality Rates , Eli Lilly X27s Eczema Drug , Lebrikizumab , Abortion Ban , Abortion Restrictions ,